These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21560354)

  • 1. [The effects of atorvastatin on aging kidney].
    Zhao JH; Cheng QL; Ye P
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Feb; 27(1):98-101. PubMed ID: 21560354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels.
    Zhao J; Cheng Q; Ye P; Yang G; Liu S; Ao Q; Liu Y; Hu Y
    Exp Gerontol; 2016 Feb; 74():37-42. PubMed ID: 26680767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atorvastatin and ezetimibe treatment on serum lipid profile and oxidative state in rats fed with a high-cholesterol diet.
    Yasim A; Ozbag D; Kilinc M; Ciralik H; Toru H; Gümüşalan Y
    Am J Med Sci; 2010 May; 339(5):448-52. PubMed ID: 20224310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
    Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
    Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of atorvastatin on eNOS synthesis in organs of aging rats with myocardial ischemia-reperfusion].
    Zhang J; Wang H; Ye P
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1708-12. PubMed ID: 23268394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
    Szapáry L; Horváth B; Márton Z; Fehér G; Tóth K; Komoly S
    Orv Hetil; 2008 Jun; 149(24):1117-23. PubMed ID: 18539578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atorvastatin on spatial memory, neuronal survival, and vascular density in female rats after traumatic brain injury.
    Qu C; Lu D; Goussev A; Schallert T; Mahmood A; Chopp M
    J Neurosurg; 2005 Oct; 103(4):695-701. PubMed ID: 16266052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin on impaired vascular function in healthy old men.
    Weverling-Rijnsburger AW; Blauw GJ; Meinders AE
    J Clin Pharm Ther; 2004 Apr; 29(2):157-64. PubMed ID: 15068405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
    Pokrovskaia EV; Vaulin NA; Gratsianskiĭ NA; Averkov OV; Deev AD
    Kardiologiia; 2003; 43(1):7-18. PubMed ID: 12891281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
    Dornbrook-Lavender KA; Joy MS; Denu-Ciocca CJ; Chin H; Hogan SL; Pieper JA
    Pharmacotherapy; 2005 Mar; 25(3):335-44. PubMed ID: 15843280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atorvastatin attenuates hypoxic pulmonary hypertension in rats by inhibiting RhoA/Rho kinase pathway].
    Dai L; Wu S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 36(1):58-63. PubMed ID: 21311140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
    Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
    Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity.
    El-Moselhy MA; El-Sheikh AA
    Biomed Pharmacother; 2014 Feb; 68(1):101-10. PubMed ID: 24268999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
    Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
    Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of atrovastatin against myocardial ischemia-reperfusion injury and on liver and kidney functions in aged rats].
    Zhang JY; Wang H; Ye P
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):322-8. PubMed ID: 22445975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinational effects of farnesoid X receptor antagonist and statin on plasma lipid levels and low-density lipoprotein clearance in guinea pigs.
    Amano Y; Ishikawa E; Shinozawa E; Shimada M; Miura S; Adachi R; Tozawa R
    Life Sci; 2014 Jul; 108(1):7-12. PubMed ID: 24805868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.